Showing results (351-360 of 362) with videos related to
Sort By:
Pageof 37
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody ResponsesMichael S Seaman, Mark J Siedner, Julie Boucau, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2019
Tetraspanin CD82 Organizes Dectin-1 into Signaling Domains to Mediate Cellular Responses to <i>Candida albicans</i>Jenny M Tam, Jennifer L Reedy, Daniel P Lukason, et al.JCI Insight|October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variantMichael S Seaman, Mark J Siedner, Julie Boucau, et al.Journal of Medicinal Chemistry|September 26, 2009
Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical developmentMark D Wittman, Joan M Carboni, Zheng Yang, et al.European Journal of Neurology|May 3, 2020
Tablet-based electroencephalography diagnostics for patients with epilepsy in the West African Republic of GuineaE Sokolov, D H Abdoul Bachir, F Sakadi, et al.Research Square|December 16, 2024
Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patientsSara V Patel, Brooke M Leeman, Patricia J Botros, et al.Mbio|November 18, 2020
Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen MotilityRichelle C Charles, Meagan Kelly, Jenny M Tam, et al.JCI Insight|April 28, 2026
Stabilizing and strengthening the U.S. physician-scientist faculty workforce in academic medicine: a proposed institutional frameworkChristopher S Williams, Megan Allen, Paige Cooper Byas, et al.Vaccines|September 27, 2025
Cross-Neutralization of Distant Coronaviruses Strongly Correlates with Spike S2-Specific Antibodies from Immunocompetent and Immunocompromised Vaccinated SARS-CoV-2-Infected PatientsSara V Patel, Brooke M Leeman, Patricia J Botros, et al.Science Translational Medicine|January 24, 2024
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.Pageof 37